Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

BRCA1 activation of the GADD45 promoter

Abstract

Breast cancer susceptibility gene BRCA1 has been implicated in the control of gene regulation and such regulated genes are thought to mediate the biological role of BRCA1. Overexpression of BRCA1 induces GADD45, a p53-regulated and stress-inducible gene. However, the molecular mechanism by which BRCA1 induces the expression GADD45 remains unclear. In this report, we have shown that the GADD45 promoter is strongly activated following expression of wild-type BRCA1. In contrast, both the tumor-derived BRCA1 mutants (p1749R and Y1853insA) and truncated BRCA1 mutant protein (Δ500–1863 BRCA1), which lack transactivation activity, were unable to activate the GADD45 promoter, indicating that the BRCA1-mediated activation of the GADD45 promoter requires normal transcriptional properties of BRCA1. BRCA1 did not induce the c-Jun and c-fos promoters, which rules out a general effect of BRCA1 on other immediate-responsive genes. Expression of the human papillomavirus E6 and the dominant-negative mutant p53 proteins had no effect on the induction of the GADD45 promoter by BRCA1, suggesting that activation of the GADD45 promoter by BRCA1 is independent of cellular p53 function. With the 5′-deletion analysis, the BRCA1-responsive element of the GADD45 promoter was mapped at the region from −121 to −75. Disruption of this region resulted in the abrogation of BRCA1 activation of the GADD45 promoter. Taken together, these results demonstrate that the mechanism by which BRCA1 induces GADD45 is mainly through the transactivation of the GADD45 promoter, further demonstrating the evidence that GADD45 acts as one of the BRCA1-regulated genes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Anderson SF, Schlegel BP, Nakajima T, Wolpin ES and Parvin JD. . 1998 Nat. Genet. 19: 254–256.

  • Carrier F, Georgel PT, Pourquier P, Blake M, Kontny HU, Antinore MJ, Gariboldi M, Myers TG, Weinstein JN, Pommier Y and Fornace Jr AJ. . 1999 Mol. Cell Biol. 19: 1673–1685.

  • Chapman MS and Verma IM. . 1996 Nature 382: 678–679.

  • Easton DF, Ford D and Bishop DT. . 1995 Am. J. Hum. Genet. 56: 265–271.

  • Ford D and Easton DF. . 1995 Br. J. Cancer 72: 805–812.

  • Fornace Jr AJ, Alamo Jr I and Hollander MC. . 1988 Proc. Natl. Acad. Sci. USA 85: 8800–8804.

  • Gowen LC, Avrutskaya AV, Latour AM, Koller BH and Leadon SA. . 1998 Science 281: 1009–1012.

  • Harkin DP, Bean JM, Miklos D, Song YH, Truong VB, Englert C, Christians FC, Ellisen LW, Maheswaran S, Oliner JD and Haber DA. . 1999 Cell 97: 575–586.

  • Holt JT, Thompson ME, Szabo C, Robinson-Benion C, Arteaga CL, King MC and Jensen RA. . 1996 Nat. Genet. 12: 298–302.

  • Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace Jr AJ. . 1992 Cell 71: 587–597.

  • Kearsey JM, Coates PJ, Prescott AR, Warbrick E and Hall PA. . 1995 Oncogene 11: 1675–1683.

  • Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW and Vogelstein B. . 1992 Science 256: 827–830.

  • Kessis TD, Slebos RJ, Nelson WG, Kastan MB, Plunkett BS, Han SM, Lorincz AT, Hedrick L and Cho KR. . 1993 Proc. Natl. Acad. Sci. USA 90: 3988–3992.

  • Larson JS, Tonkinson JL and Lai MT. . 1997 Cancer Res. 57: 3351–3355.

  • Marquis ST, Rajan JV, Wynshaw-Boris A, Xu J, Yin GY, Abel KJ, Weber BL and Chodosh LA. . 1995 Nat. Genet. 11: 17–26.

  • Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayanath P, Ward J, Tonin P, Narod S, Bristow P, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A and Skolnick MH. . 1994 Science 266: 66–71.

  • Ouchi T, Monteiro AN, August A, Aaronson SA and Hanafusa H. . 1998 Proc. Natl. Acad. Sci. USA 95: 2302–2306.

  • Papathanasiou MA, Kerr NC, Robbins JH, McBride OW, Alamo Jr I, Barrett SF, Hickson ID and Fornace Jr AJ. . 1991 Mol. Cell Biol. 11: 1009–1016.

  • Rajan JV, Wang M, Marquis ST and Chodosh LA. . 1996 Proc. Natl. Acad. Sci. USA 93: 13078–13083.

  • Rao VN, Shao N, Ahmad M and Reddy ES. . 1996 Oncogene 12: 523–528.

  • Scully R, Chen J, Ochs RL, Keegan K, Hoekstra M, Feunteun J and Livingston DM. . 1997 Cell 90: 425–435.

  • Shen SX, Weaver Z, Xu X, Li C, Weinstein M, Chen L, Guan XY, Ried T and Deng CX. . 1998 Oncogene 17: 3115–3124.

  • Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM, Kastan MB, O'Connor PM and Fornace Jr AJ. . 1994 Science 266: 1376–1380.

  • Smith ML, Kontny HU, Zhan Q, Sreenath A, O'Connor PM and Fornace Jr AJ. . 1996 Oncogene 13: 2255–2263.

  • Somasundaram K, Zhang H, Zeng YX, Houvras Y, Peng Y, Wu GS, Licht JD, Weber BL and El-Deiry WS. . 1997 Nature 389: 187–190.

  • Takekawa M and Saito H. . 1998 Cell 95: 521–530.

  • Thakur S, Zhang HB, Peng Y, Le H, Carroll B, Ward T, Yao J, Farid LM, Couch FJ, Wilson RB and Weber BL. . 1997 Mol. Cell Biol. 17: 444–452.

  • Thompson ME, Jensen RA, Obermiller PS, Page DL and Holt JT. . 1995 Nat. Genet. 9: 444–450.

  • Vaughn JP, Davis PL, Jarboe MD, Huper G, Evans AC, Wiseman RW, Berchuck A, Iglehart JD, Futreal PA.and Marks JR. . 1996 Cell. Growth Differ. 7: 711–715.

  • Wang Q, Zhang H, Kajino K and Greene MI. . 1998 Oncogene 17: 1939–1948.

  • Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L, Hollander MC, O'Connor PM, Fornace Jr AJ and Harris CC. . 1999 Proc. Natl. Acad. Sci. USA 96: 3706–3711.

  • Zhan Q, Antinore MJ, Wang XW, Carrier F, Smith ML, Harris CC and Fornace Jr AJ. . 1999 Oncogene 18: 2892–2900.

  • Zhan Q, Bae I, Kastan MB and Fornace Jr AJ. . 1994a Cancer Res. 54: 2755–2760.

  • Zhan Q, Carrier F and Fornace Jr AJ. . 1993 Mol. Cell Biol. 13: 4242–4250.

  • Zhan Q, Chen IT, Antinore MJ and Fornace Jr AJ. . 1998 Mol. Cell Biol. 18: 2768–2778.

  • Zhan Q, Fan S, Smith ML, Bae I, Yu K, Alamo Jr I, O'Connor PM and Fornace Jr AJ. . 1996 DNA Cell Biol. 15: 805–815.

  • Zhan Q, Lord KA, Alamo Jr I, Hollander MC, Carrier F, Ron D, Kohn KW, Hoffman B, Liebermann DA and Fornace Jr AJ. . 1994b Mol. Cell Biol. 14: 2361–2371.

  • Zhang H, Somasundaram K, Peng Y, Tian H, Bi D, Weber BL and El-Deiry WS. . 1998 Oncogene 16: 1713–1721.

Download references

Acknowledgements

The authors are grateful to Dr Barbara Weber for the generous gifts of all BRCA-1 related expression plasmids. This work was supported by grant BC991175 from the Department of the Army.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jin, S., Zhao, H., Fan, F. et al. BRCA1 activation of the GADD45 promoter . Oncogene 19, 4050–4057 (2000). https://doi.org/10.1038/sj.onc.1203759

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203759

Keywords

This article is cited by

Search

Quick links